3.7750
-0.1250
(-3.21%)
At close: March 3 at 9:52:07 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-22,126
-23,935
-27,023
-36,715
-34,778
Investing Cash Flow
-23,719
15,541
-23,276
21,560
44,769
Financing Cash Flow
30,420
7,855
--
62,158
1,310
End Cash Position
4,680
12,620
13,159
63,458
16,455
Capital Expenditure
--
-34
-269
-5
-76
Issuance of Capital Stock
16,405
7,843
--
60,943
1,222
Free Cash Flow
-22,126
-23,969
-27,292
-36,720
-34,854
12/31/2020 - 7/9/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
W2J.F Carisma Therapeutics, Inc.
0.3716
-1.80%
1VT.SG Viking Therapeutics Inc
24.54
-11.89%
1VT.DU Viking Therapeutics Inc
24.59
-10.39%
W2J.SG CARISMA Therapeutics Inc
0.3740
-2.76%
0M4.DU Mersana Therapeutics Inc
0.4683
-0.49%
0M4.F Mersana Therapeutics, Inc.
0.4229
-0.33%
0M4.BE Mersana Therapeutics Inc
0.4663
-1.71%
CYCCP Cyclacel Pharmaceuticals, Inc.
7.83
+12.66%
0M4.MU Mersana Therapeutics Inc
0.4915
0.00%
OBD.L Oxford BioDynamics Plc
0.5150
-6.70%